Market Capitalization (Millions $) |
20 |
Shares
Outstanding (Millions) |
57 |
Employees |
84 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-44 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Elevation Oncology Inc
Elevation Oncology Inc. is a biopharmaceutical company that focuses on developing precision medicines for patients with genomically defined cancers. The company utilizes a biomarker-driven approach to identify and target the specific genetic alterations that drive cancer growth. Their aim is to improve patient outcomes by providing personalized therapies based on the specific genomic profiles of their tumors. Elevation Oncology's research and development efforts are centered around identifying new drug candidates and advancing them through clinical trials to ultimately bring novel treatments to cancer patients in need.
Company Address: 101 Federal Street Boston 2110 MA
Company Phone Number: 371-1125 Stock Exchange / Ticker: NASDAQ ELEV
|